| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 69.97B | 63.75B | 51.61B | 42.01B | 39.15B | 35.43B |
| Gross Profit | 15.17B | 13.66B | 11.26B | 8.89B | 8.21B | 5.68B |
| EBITDA | 8.20B | 8.49B | 7.21B | 4.70B | 4.26B | 1.77B |
| Net Income | 5.20B | 4.17B | 3.38B | 2.19B | 1.93B | 1.07B |
Balance Sheet | ||||||
| Total Assets | 105.89B | 99.82B | 82.76B | 72.36B | 65.04B | 60.57B |
| Cash, Cash Equivalents and Short-Term Investments | 7.81B | 11.74B | 13.71B | 12.86B | 11.84B | 10.38B |
| Total Debt | 9.89B | 10.38B | 10.04B | 9.99B | 9.72B | 10.00B |
| Total Liabilities | 65.94B | 64.01B | 50.40B | 42.49B | 41.79B | 38.92B |
| Stockholders Equity | 39.62B | 35.50B | 32.03B | 29.49B | 22.98B | 21.47B |
Cash Flow | ||||||
| Free Cash Flow | 5.06B | 1.89B | 2.92B | 2.34B | 3.19B | 2.91B |
| Operating Cash Flow | 11.04B | 6.73B | 6.46B | 4.65B | 5.71B | 5.80B |
| Investing Cash Flow | -8.48B | -4.18B | -5.92B | -2.44B | -4.70B | -4.00B |
| Financing Cash Flow | -2.08B | -1.93B | -1.23B | -1.18B | -1.64B | -1.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $92.13B | 22.10 | 17.78% | 1.74% | 11.86% | 17.39% | |
75 Outperform | $81.27B | 20.44 | 26.15% | 1.54% | -0.14% | 72.35% | |
70 Outperform | $104.37B | 25.18 | 62.78% | 2.92% | 2.88% | -35.15% | |
70 Neutral | $51.69B | 29.67 | 9.13% | 1.74% | 2.83% | 47.00% | |
69 Neutral | $29.30B | 57.68 | 13.59% | 0.44% | 27.43% | 35.56% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | $41.40B | 166.07 | 10.03% | ― | 31.77% | -15.34% |